Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial (vol 205, pg 1290, 2022)
American Journal of Respiratory and Critical Care Medicine
; 206(6):801-801, 2022.
Article
in English
| Web of Science | ID: covidwho-2067946
Search on Google
Collection:
Databases of international organizations
Database:
Web of Science
Type of study:
Experimental Studies
/
Randomized controlled trials
Language:
English
Journal:
American Journal of Respiratory and Critical Care Medicine
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS